Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic
European Heart Journal - Cardiovascular Pharmacotherapy · 2024
DOI: 10.1093/ehjcvp/pvae061 ↗Kurz gefasst
Editorial in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, 2024. Verfasst von Stefan Agewall. Beteiligte Einrichtung: Editor-in-Chief. Hauptthemen laut MEDLINE: Hypolipidemic Agents. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Editor-in-Chief.
- Institute of Clinical Sciences, Karolinska Institute of Danderyd, Stockholm, Sweden.
ORCID-Profile: Stefan Agewall
Zitieren
APA
Agewall, S. (2024). Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae061
Vancouver
Agewall S. Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic. European Heart Journal - Cardiovascular Pharmacotherapy. 2024. doi:10.1093/ehjcvp/pvae061
BibTeX
@article{Agewall2024,
author = {Agewall, Stefan},
title = {Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic},
journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
year = {2024},
doi = {10.1093/ehjcvp/pvae061}
}
EUVIMED